Yang Yifan,Jiang Jingying,Qian Manning,et al.Value of serum bile acid levels in prognostic evaluation of successful jaundice resolution after Kasai procedure for biliary atresia[J].Journal of Clinical Pediatric Surgery,,():711-715.[doi:10.3760/cma.j.cn101785-202405062-003]
Click Copy

Value of serum bile acid levels in prognostic evaluation of successful jaundice resolution after Kasai procedure for biliary atresia

References:

[1] Okubo R,Nio M,Sasaki H,et al.Impacts of early Kasai portoenterostomy on short-term and long-term outcomes of biliary atresia[J].Hepatol Commun,2021,5(2):234-243.DOI:10.1002/hep4.1615.
[2] 郑露露,吴一波,吴伟,等.Ⅲ型胆道闭锁Kasai手术后患儿自体肝中长期生存情况的影响因素分析[J].临床小儿外科杂志,2023,22(11):1045-1049.DOI:10.3760/cma.j.cn101785-202203017-008. Zheng LL,Wu YB,Wu W,et al.Middle/long-term prognosis and influencing factors of Kasai portoenterostomy on type Ⅲ biliary atresia[J].DOI:10.3760/cma.j.cn101785-202203017-008.
[3] Wang ZM,Chen YJ,Peng CH,et al.Five-year native liver survival analysis in biliary atresia from a single large Chinese center:the death/liver transplantation hazard change and the importance of rapid early clearance of jaundice[J].J Pediatr Surg,2019,54(8):1680-1685.DOI:10.1016/j.jpedsurg.2018.09.025.
[4] Fanna M,Masson G,Capito C,et al.Management of biliary atresia in France 1986 to 2015:long-term results[J].J Pediatr Gastroenterol Nutr,2019,69(4):416-424.DOI:10.1097/MPG.0000000000002446.
[5] Johansson H,Svensson JF,Almstr?m M,et al.Regulation of bile acid metabolism in biliary atresia:reduction of FGF19 by Kasai portoenterostomy and possible relation to early outcome[J].J Intern Med,2020,287(5):534-545.DOI:10.1111/joim.13028.
[6] Virk MK,Mian MUM,Bashir DA,et al.Elevated bile acids are associated with left ventricular structural changes in biliary atresia[J].Hepatol Commun,2023,7(5):e0109.DOI:10.1097/HC9.0000000000000109.
[7] Yokoyama S,Ishigami M,Honda T,et al.Spleen stiffness by 2-D shear wave elastography is the most accurate predictor of high-risk esophagogastric varices in children with biliary atresia[J].Hepatol Res,2019,49(10):1162-1168.DOI:10.1111/hepr.13381.
[8] Bass LM,Shneider BL,Henn L,et al.Clinically evident portal hypertension:an operational research definition for future investigations in the pediatric population[J].J Pediatr Gastroenterol Nutr,2019,68(6):763-767.DOI:10.1097/MPG.0000000000002333.
[9] Hukkinen M,Kerola A,Lohi J,et al.Very low bilirubin after portoenterostomy improves survival of the native liver in patients with biliary atresia by deferring liver fibrogenesis[J].Surgery,2019,165(4):843-850.DOI:10.1016/j.surg.2018.10.032.
[10] Hukkinen M,Ruuska S,Pihlajoki M,et al.Long-term outcomes of biliary atresia patients surviving with their native livers[J].Best Pract Res Clin Gastroenterol,2022,56/57:101764.DOI:10.1016/j.bpg.2021.101764.
[11] Polkowska G,Polkowski W,Kudlicka A,et al.Range of serum bile acid concentrations in neonates,infants,older children,and in adults[J].Med Sci Monit,2001,7(Suppl 1):268-270.
[12] Kawasaki H,Yamanishi Y,Miyake M,et al.Age-and sex-related profiles of serum primary and total bile acids in infants,children and adults[J].Tohoku J Exp Med,1986,150(3):353-357.DOI:10.1620/tjem.150.353.
[13] Baghdasaryan A,Chiba P,Trauner M.Clinical application of transcriptional activators of bile salt transporters[J].Mol Aspects Med,2014,37(100):57-76.DOI:10.1016/j.mam.2013.12.001.
[14] Chen HL,Liu YJ,Chen HL,et al.Expression of hepatocyte transporters and nuclear receptors in children with early and late-stage biliary atresia[J].Pediatr Res,2008,63(6):667-673.DOI:10.1203/PDR.0b013e318170a6b5.
[15] Boyer JL,Trauner M,Mennone A,et al.Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTα-OSTβ in cholestasis in humans and rodents[J].Am J Physiol Gastrointest Liver Physiol,2006,290(6):G1124-G1130.DOI:10.1152/ajpgi.00539.2005.
[16] Shneider BL,Fox VL,Schwarz KB,et al.Hepatic basolateral sodium-dependent-bile acid transporter expression in two unusual cases of hypercholanemia and in extrahepatic biliary atresia[J].Hepatology,1997,25(5):1176-1183.DOI:10.1002/hep.510250521.
[17] Karpen SJ,Kelly D,Mack C,et al.Ileal bile acid transporter inhibition as an anticholestatic therapeutic target in biliary atresia and other cholestatic disorders[J].Hepatol Int,2020,14(5):677-689.DOI:10.1007/s12072-020-10070-w.
[18] 陈功,朱叶,武少静.胆汁酸代谢相关药物在胆道闭锁治疗中的应用与展望[J].临床小儿外科杂志,2020,19(6):473-476.DOI:10.3969/j.issn.1671-6353.2020.06.002. Chen G,Zhu Y,Wu SJ.Applications and future prospects of drugs related to bile acid metabolism in biliary atresia[J].J Clin Ped Sur,2020,19(6):473-476.DOI:10.3969/j.issn.1671-6353.2020.06.002.

Memo

收稿日期:2024-5-26。
基金项目:国家自然科学基金(82270541);上海市临床重点专科(shslczdzk05703)
通讯作者:郑珊,Email:szheng@shmu.edu.cn

Last Update: 1900-01-01